×
S&P 500   3,768.78 (-1.48%)
DOW   30,545.40 (-1.77%)
QQQ   279.58 (-0.90%)
AAPL   139.21 (+0.20%)
MSFT   257.77 (-0.70%)
META   162.99 (+1.85%)
GOOGL   2,192.94 (+0.84%)
AMZN   111.37 (+1.65%)
TSLA   669.44 (-1.81%)
NVDA   145.93 (+0.48%)
NIO   21.36 (-0.56%)
BABA   115.06 (-0.81%)
AMD   73.59 (-0.11%)
MU   54.87 (+2.27%)
CGC   2.66 (-5.34%)
T   20.87 (-2.06%)
GE   61.04 (-3.93%)
F   10.90 (-3.71%)
DIS   94.62 (-1.58%)
AMC   12.85 (-5.03%)
PFE   50.57 (-3.33%)
PYPL   72.08 (+0.95%)
NFLX   180.05 (+0.06%)
S&P 500   3,768.78 (-1.48%)
DOW   30,545.40 (-1.77%)
QQQ   279.58 (-0.90%)
AAPL   139.21 (+0.20%)
MSFT   257.77 (-0.70%)
META   162.99 (+1.85%)
GOOGL   2,192.94 (+0.84%)
AMZN   111.37 (+1.65%)
TSLA   669.44 (-1.81%)
NVDA   145.93 (+0.48%)
NIO   21.36 (-0.56%)
BABA   115.06 (-0.81%)
AMD   73.59 (-0.11%)
MU   54.87 (+2.27%)
CGC   2.66 (-5.34%)
T   20.87 (-2.06%)
GE   61.04 (-3.93%)
F   10.90 (-3.71%)
DIS   94.62 (-1.58%)
AMC   12.85 (-5.03%)
PFE   50.57 (-3.33%)
PYPL   72.08 (+0.95%)
NFLX   180.05 (+0.06%)
S&P 500   3,768.78 (-1.48%)
DOW   30,545.40 (-1.77%)
QQQ   279.58 (-0.90%)
AAPL   139.21 (+0.20%)
MSFT   257.77 (-0.70%)
META   162.99 (+1.85%)
GOOGL   2,192.94 (+0.84%)
AMZN   111.37 (+1.65%)
TSLA   669.44 (-1.81%)
NVDA   145.93 (+0.48%)
NIO   21.36 (-0.56%)
BABA   115.06 (-0.81%)
AMD   73.59 (-0.11%)
MU   54.87 (+2.27%)
CGC   2.66 (-5.34%)
T   20.87 (-2.06%)
GE   61.04 (-3.93%)
F   10.90 (-3.71%)
DIS   94.62 (-1.58%)
AMC   12.85 (-5.03%)
PFE   50.57 (-3.33%)
PYPL   72.08 (+0.95%)
NFLX   180.05 (+0.06%)
S&P 500   3,768.78 (-1.48%)
DOW   30,545.40 (-1.77%)
QQQ   279.58 (-0.90%)
AAPL   139.21 (+0.20%)
MSFT   257.77 (-0.70%)
META   162.99 (+1.85%)
GOOGL   2,192.94 (+0.84%)
AMZN   111.37 (+1.65%)
TSLA   669.44 (-1.81%)
NVDA   145.93 (+0.48%)
NIO   21.36 (-0.56%)
BABA   115.06 (-0.81%)
AMD   73.59 (-0.11%)
MU   54.87 (+2.27%)
CGC   2.66 (-5.34%)
T   20.87 (-2.06%)
GE   61.04 (-3.93%)
F   10.90 (-3.71%)
DIS   94.62 (-1.58%)
AMC   12.85 (-5.03%)
PFE   50.57 (-3.33%)
PYPL   72.08 (+0.95%)
NFLX   180.05 (+0.06%)
NASDAQ:KRMD

Repro Med Systems Stock Forecast, Price & News

$2.45
-0.08 (-3.16%)
(As of 07/1/2022 08:00 PM ET)
Add
Compare
Today's Range
$2.45
$2.45
50-Day Range
$1.95
$2.89
52-Week Range
$1.82
$4.16
Volume
49,400 shs
Average Volume
42,062 shs
Market Capitalization
$109.93 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Repro Med Systems MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Bearish
0.76% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.94mentions of Repro Med Systems in the last 14 days
Based on 3 Articles This Week
Insider Trading
Acquiring Shares
$80,400 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($0.22) to ($0.18) Per Share

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

1.09 out of 5 stars

Medical Sector

1070th out of 1,428 stocks

Surgical & Medical Instruments Industry

108th out of 138 stocks

30 days | 90 days | 365 days | Advanced Chart

Receive KRMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Repro Med Systems and its competitors with MarketBeat's FREE daily newsletter.

Repro Med Systems logo

About Repro Med Systems (NASDAQ:KRMD) Stock

Repro Med Systems, Inc., doing business as KORU Medical Systems, designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. It offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company also provides education and training materials to clinicians, patients, and patient advocates. It sells its products through direct sales and medical device distributors, as well as online. Repro Med Systems, Inc. was incorporated in 1980 and is headquartered in Chester, New York.

KRMD Stock News Headlines

KORU Medical Systems appoints Brian Case as CTO
Preview: Repro-Med Systems's Earnings
See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:KRMD
Employees
77
Year Founded
N/A

Company Calendar

Last Earnings
5/04/2022
Today
7/05/2022
Next Earnings (Estimated)
8/10/2022
Fiscal Year End
12/31/2022

Profitability

Net Income
$-4,560,000.00
Pretax Margin
-29.96%

Debt

Sales & Book Value

Annual Sales
$23.49 million
Book Value
$0.82 per share

Miscellaneous

Free Float
29,614,000
Market Cap
$109.93 million
Optionable
Not Optionable
Beta
0.31














Repro Med Systems Frequently Asked Questions

How has Repro Med Systems' stock price performed in 2022?

Repro Med Systems' stock was trading at $3.00 on January 1st, 2022. Since then, KRMD stock has decreased by 18.3% and is now trading at $2.45.
View the best growth stocks for 2022 here
.

When is Repro Med Systems' next earnings date?

Repro Med Systems is scheduled to release its next quarterly earnings announcement on Wednesday, August 10th 2022.
View our earnings forecast for Repro Med Systems
.

How were Repro Med Systems' earnings last quarter?

Repro Med Systems, Inc. (NASDAQ:KRMD) issued its quarterly earnings data on Wednesday, May, 4th. The company reported ($0.05) EPS for the quarter, topping analysts' consensus estimates of ($0.06) by $0.01. The company earned $6.24 million during the quarter, compared to analysts' expectations of $5.97 million. Repro Med Systems had a negative trailing twelve-month return on equity of 13.57% and a negative net margin of 23.97%.
View Repro Med Systems' earnings history
.

What guidance has Repro Med Systems issued on next quarter's earnings?

Repro Med Systems issued an update on its FY 2022 earnings guidance on Monday, May, 16th. The company provided EPS guidance of for the period. The company issued revenue guidance of $26.50 million-$27.00 million, compared to the consensus revenue estimate of $26.31 million.

Who are Repro Med Systems' key executives?

Repro Med Systems' management team includes the following people:
  • Ms. Linda M. Tharby, Pres, CEO & Director (Age 54, Pay $829.06k)
  • Ms. Karen Fisher, CFO, Treasurer & Corp. Sec. (Age 56, Pay $297.99k)
  • Mr. Manuel A. Marques, Chief Operating Officer (Age 49, Pay $260.25k)
  • Mr. Brian Case, Chief Technology Officer
  • Mr. Rob Cannon, VP of Sales

What other stocks do shareholders of Repro Med Systems own?

What is Repro Med Systems' stock symbol?

Repro Med Systems trades on the NASDAQ under the ticker symbol "KRMD."

How do I buy shares of Repro Med Systems?

Shares of KRMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Repro Med Systems' stock price today?

One share of KRMD stock can currently be purchased for approximately $2.45.

How much money does Repro Med Systems make?

Repro Med Systems (NASDAQ:KRMD) has a market capitalization of $109.93 million and generates $23.49 million in revenue each year. The company earns $-4,560,000.00 in net income (profit) each year or ($0.13) on an earnings per share basis.

How many employees does Repro Med Systems have?

Repro Med Systems employs 77 workers across the globe.

How can I contact Repro Med Systems?

Repro Med Systems' mailing address is 24 CARPENTER RD, CHESTER NY, 10918. The official website for Repro Med Systems is www.korumedical.com. The company can be reached via phone at (845) 469-2042, via email at dsullivan@equityny.com, or via fax at 845-469-5518.

This page (NASDAQ:KRMD) was last updated on 7/5/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.